Funding & conflicts
Funding model
skinoncology.net is entirely self-funded by its Editor-in-Chief — a Consultant Plastic and Reconstructive Surgeon with a sub-specialty interest in skin oncology and reconstruction. Editorial board members give their time voluntarily and are not paid. There are no subscriptions, paywalls, login walls or institutional licences. All clinical content is free to access for any UK or international healthcare professional.
No advertising
The site carries no advertising of any kind. There are no display ads, programmatic ads, native ads, banner ads, sponsored placements or affiliate links anywhere on the site. This is a deliberate decision to keep the reading experience clean and remove any perception of commercial influence on clinical content.
Anonymous analytics (opt-in)
Google Analytics 4 is used to count anonymous page views and understand which content is useful — only if you accept the cookie banner. No advertising features, no Google Signals, no demographics, no profile building. IP addresses are anonymised. You can withdraw consent any time via the Cookie preferences link in the footer. Full disclosure is in the privacy notice.
No commercial sponsorship of editorial content
The site does not accept commercial sponsorship of clinical content. Pharmaceutical, device, diagnostic and digital-health companies have no editorial influence:
- No paid placements, sponsored monographs, sponsored guidelines or sponsored cases.
- No company sight of, or input into, clinical content before publication.
- No selection of topics or framing of recommendations on the basis of commercial relationships.
- No company logos within clinical pages.
Conflicts of interest
The Editor-in-Chief declares no financial relationships within the last three years with pharmaceutical, device, diagnostic or digital-health companies active in skin cancer that could be perceived as a conflict relating to content on this site, and his NHS clinical income is unrelated to and unaffected by this site. Editorial board members' declarations of interest are stated on their individual profiles.
If this position changes — for example through participation in a clinical trial, an advisory role or an honorarium — it will be disclosed here promptly.
Reporting concerns
Concerns about editorial integrity can be reported via the contact page. Reports are reviewed by the editorial team within 30 days and any necessary correction is made on the affected page with a visible note.
Why this matters
No advertising and no commercial sponsorship gives the site a clear, declarable editorial position. Readers should still apply normal critical appraisal: see the editorial approach and about the author pages.